INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 2 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,633,000 | -19.9% | 53,500 | -27.9% | 0.01% | -25.0% |
| Q1 2016 | $9,532,000 | +211.3% | 74,200 | +262.0% | 0.01% | +300.0% |
| Q4 2015 | $3,062,000 | -21.1% | 20,500 | -12.4% | 0.00% | -25.0% |
| Q3 2015 | $3,881,000 | -21.9% | 23,400 | +13.6% | 0.00% | 0.0% |
| Q2 2015 | $4,972,000 | -68.0% | 20,600 | -62.6% | 0.00% | -73.3% |
| Q1 2015 | $15,539,000 | +356.9% | 55,100 | +152.8% | 0.02% | +400.0% |
| Q4 2014 | $3,401,000 | -52.4% | 21,800 | -27.8% | 0.00% | -57.1% |
| Q3 2014 | $7,148,000 | +22.8% | 30,200 | +22.8% | 0.01% | 0.0% |
| Q2 2014 | $5,821,000 | -36.0% | 24,600 | -10.9% | 0.01% | -36.4% |
| Q1 2014 | $9,102,000 | – | 27,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,200,000 | $22,248,000 | 10.22% |
| GROUP ONE TRADING, L.P. | 24,800 | $459,792 | 0.00% |
| SIMPLEX TRADING, LLC | 53,200 | $986 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 68,500 | $1,269,990 | 0.00% |